Publications by authors named "Shunya Takemoto"
Article Synopsis
- Atopic dermatitis (AD) is a chronic skin condition that significantly impacts patients' quality of life due to itching and discomfort, making it essential to understand its treatment and management.
- A cross-sectional study, MEASURE-AD, examined treatment patterns and the overall burden of moderate-to-severe AD across 28 countries, involving 1,591 patients.
- Results showed that most patients were on medication, with over half receiving systemic treatments, and those on systemic therapy experienced a lower burden from the disease compared to those not on such treatments.
Introduction: Treatment satisfaction in patients with atopic dermatitis (AD) has been investigated in several studies, but the desire for alternative treatment options is unclear and has not been previously evaluated. We conducted a cross-sectional, web-based survey aimed at evaluating the desire for alternative treatment options in adults with AD from a patient registry in Japan.
Methods: Main eligibility criteria were adults aged ≥ 18 years with AD who were receiving treatment with topical corticosteroids (TCS) and not systemic therapy.